Castle Biosciences (CSTL) PT Raised to $36 at KeyBanc
Tweet Send to a Friend
(Updated - November 5, 2024 11:49 AM EST)
KeyBanc analyst Paul Knight raised the price target on Castle Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
KeyBanc analyst Paul Knight raised the price target on Castle Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
